Shulman points out that, while some medications exist to treat fatty liver disease, including the newly FDA-approved drug ...
Hosted on MSN5mon
Expanding horizons in Parkinson's disease care with non-pharmacological interventionsKalia, MD, PhD, Krembil Research Institute, Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health ...
News Medical on MSN15d
ITSN1 gene linked to substantial risk of Parkinson’s diseaseA new study led by researchers at researchers at Baylor College of Medicine, AstraZeneca and the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital reveals a breakthrough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results